financetom
Business
financetom
/
Business
/
Hess-Chevron merger vote appears ripe for narrow approval
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hess-Chevron merger vote appears ripe for narrow approval
May 23, 2024 12:04 PM

HOUSTON, May 23 (Reuters) - Hess Corp ( HES ) CEO John Hess has

until Tuesday to quell a rebellion by shareholders over his

handling of what could turn out to be one of the largest mergers

in oil industry history: a proposed $53 billion sale of the oil

producer to Chevron Corp. ( CVX )

Hess, 70, has spent the past month visiting or calling

dozens of investors to gather support. The sale seemed all but

certain last fall and Hess still appears poised to win, based on

Reuters' interviews with large investors. But support has

slipped in recent weeks with more investment funds voicing

concerns about the deal.

A lengthy U.S. federal regulatory review and a surprise

arbitration challenge from Exxon Mobil ( XOM ) have put about

40% of shares outstanding on the fence, interviews show.

That could make it harder for Hess to get more than 50% of

the 308 million shares outstanding to win approval, even though

he can count on his family shares along with other directors and

management, for about 10%.

Hess has lost about $5 billion in market value since the

deal was announced. Every quarter the merger is delayed, its

shareholders lose the chance for a dividend payment from Chevron ( CVX )

-- a major incentive since Chevron's ( CVX ) dividend is four times

bigger than the Hess payout.

"This is the mother of all embarrassments," said a

London-based investor who declined to be named, adding that if

Hess shareholders approve this deal, chances will fade for a

higher bid.

TIGHT SCOREBOARD

Three firms - HBK Capital Management, D.E. Shaw & Co, and

Pentwater Capital Management - have stated they are not ready to

give their go ahead. Together they hold almost 6% of Hess.

Another three investors filed lawsuits to delay or block the

vote, backed by a flood of letters to Hess management

complaining it failed to disclose legal and regulatory issues

that could delay the transaction by up to one year.

Six large investors who spoke with Reuters under condition

of anonymity estimated firms holding about 40% of the company's

stock have decided or are strongly considering abstaining,

essentially a no vote.

"The longer this takes, the more I would begin to question

the value proposition of this merger," said Roy Behren,

co-president of Westchester Capital Management, which holds $317

million in Hess shares and is considering an abstention.

The delays have shrunk expected profits for arbitrage

funds that pounced on Hess shares after the deal was announced

betting it would close in the first quarter.

Fayez Sarofim & Co, Invesco ( IVZ ) and Barrow Hanley which hold some

3% of outstanding shares worth about $1.5 billion, are expected

to vote yes, according to people familiar with the matter. The

three firms declined requests for comment.

Influential proxy advisor Institutional Shareholder Services

(ISS) has recommended abstention to give more time for details

of the arbitration case to emerge. Rival Glass Lewis,

recommended a vote in favor, saying the Chevron ( CVX ) deal merits are

sound and offer Hess shareholders a premium.

Top investment firm Vanguard Group, with 10% of Hess shares,

holds the largest individual stake. Votes of its portfolio

managers could swing the outcome. Vanguard declined to disclose

its vote.

EXXON AS POSSIBLE SPOILER

This year, Exxon and partner CNOOC Ltd filed an arbitration

case claiming they have a first right of refusal to buy Hess'

Guyana assets. Chevron ( CVX ) and Hess say a right of refusal does not

apply to sale of the entire company. If Exxon's arbitration

succeeds, Chevron ( CVX ) could walk away from the deal without paying a

break up fee.

In recent private meetings, John Hess told investors he did

not know Exxon's end game with the arbitration. If Exxon

succeeds, Hess and Chevron ( CVX ) say they would call off the deal, and

Hess said this would mean Exxon could not exercise its right of

first refusal on the Guyana assets.

If the arbitration succeeds and Chevron ( CVX ) walks away, Hess

would have few alternate buyers given the pre-emption right to

any future deal, said Biraj Borkhataria, an energy analyst with

researcher RBC Capital Markets.

Chevron ( CVX ) sorely needs the deal to keep up with rival Exxon,

which this month closed its $60 billion acquisition of shale

producer Pioneer Natural Resources.

The lucrative Guyana oilfields from Hess would help Chevron ( CVX )

hedge geopolitical risks associated with TengizChevroil project

in Kazakhstan, which moves most of its oil across Russia to a

Black Sea port. It would also help balance overruns at Chevron's ( CVX )

Australian liquefied natural gas (LNG) projects, hit by labor

and operating troubles.

A spokesperson said Chevron ( CVX ) "looks forward to Hess obtaining

a successful shareholder vote and completing the transaction on

the terms of our merger agreement." Last month, CEO Michael

Wirth said Chevron ( CVX ) would be in good shape regardless of the

acquisition.

Some Hess shareholders wonder if Exxon would make a

higher offer for the Guyana assets than what they would get from

Chevron's ( CVX ) bid for the company. There are no legal impediments to

an Exxon offer before Tuesday, but Exxon has said it wanted to

have its rights over the Guyana asset affirmed before making any

decision on a bid.

Exxon has also said it would not seek to acquire Hess as a

whole.

"I don't see how Exxon can bid (for Hess) when they have

said they would not," said oil analyst Paul Sankey, from Sankey

Research firm. "Unless they wait a while, and things change a

lot. I mean years."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves X4 Pharmaceuticals' drug for immunodeficiency disease
US FDA approves X4 Pharmaceuticals' drug for immunodeficiency disease
Apr 29, 2024
April 29 (Reuters) - The U.S. FDA has approved X4 Pharmaceuticals' ( XFOR ) drug to treat a rare genetic immunodeficiency disease, the company said on Monday. (Reporting by Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli) ...
Wall Financial Q4 Profit Drops, Revenue Rises
Wall Financial Q4 Profit Drops, Revenue Rises
Apr 29, 2024
06:26 AM EDT, 04/29/2024 (MT Newswires) -- Wall Financial ( WFICF ) , a British Columbia-based real estate company, over the weekend reported fourth-quarter net earnings attributable to shareholders of $551,495, or $0.02 per share, down from $1.7 million, or $0.05 per share, a year earlier. Total revenue and other income for the quarter ended Jan. 31, was $33.3 million,...
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook
Apr 29, 2024
06:35 AM EDT, 04/29/2024 (MT Newswires) -- Royal Philips' (PHG) US-listed shares surged early Monday after reaching a $1.1 billion settlement related to personal injury litigation in the US, while the Dutch health technology firm reiterated its full-year comparable sales growth outlook. The settlement resolves all claims filed in the US over Philips' recalled sleep and respiratory care products, with...
West Red Lake Gold Updates Mineral Resource Estimate for Rowan Mine Deposit in Ontario
West Red Lake Gold Updates Mineral Resource Estimate for Rowan Mine Deposit in Ontario
Apr 29, 2024
06:35 AM EDT, 04/29/2024 (MT Newswires) -- West Red Lake Gold Mines ( WRLGF ) over the weekend said it updated its mineral resource estimate as of March 1 on its Rowan mine deposit in the Red Lake Gold District of northwestern Ontario in Canada. The 2024 mineral resource estimate has added a significant portion of higher confidence indicated ounces...
Copyright 2023-2026 - www.financetom.com All Rights Reserved